Skip to main content

Advertisement

SpringerLink
Log in

New Advances in the Treatment of Acute Pancreatitis

  • Pancreas (V Chandrasekhara, Section Editor)
  • Published:
Current Treatment Options in Gastroenterology Aims and scope Submit manuscript

Abstract

Purpose of review

Despite the increasing incidence of acute pancreatitis, the overall mortality of AP has decreased.

Recent findings

The findings of recent studies on fluid therapy, analgesics, antibiotics, and enteral nutrition as well as the management of AP complications have led to improvements in clinical care. However, there are still no pharmacologic treatment(s) for AP.

Summary

Experimental studies have revealed many potential therapeutic targets, but these will need to be further developed and tested before they can be assessed in randomized controlled trials with important clinical endpoints.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Peery AF, Crockett SD, Barritt AS, Dellon ES, Eluri S, Gangarosa LM, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149:1741.e3.

    Google Scholar 

  2. Fagenholz PJ, Fernandez-del Castillo C, Harris NS, Pelletier AJ, Camargo CA. Direct medical costs of acute pancreatitis hospitalizations in the United States. Pancreas. 2007a;35:302–7.

    Article  Google Scholar 

  3. • Krishna SG, Kamboj AK, Hart PA, Hinton A, Conwell DL. The changing epidemiology of acute pancreatitis hospitalizations: a decade of trends and the impact of chronic pancreatitis. Pancreas. 2017;46:482–8. Large administrative database study which showed that AP hospitalizations have increased but the overall mortality of AP has decreased over a 10-year period in the USA.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Fagenholz PJ, Castillo CF, Harris NS, Pelletier AJ, Camargo CA. Increasing United States hospital admissions for acute pancreatitis, 1988-2003. Ann Epidemiol. 2007b;17:491–7.

    Article  Google Scholar 

  5. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Acute pancreatitis classification working group. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–11.

    Article  Google Scholar 

  6. Gorelick FS, Lerch MM. Do animal models of acute pancreatitis reproduce human disease? Cell Mol Gastroenterol Hepatol. 2017;4:251–62.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Afghani E, Pandol SJ, Shimosegawa T, Sutton R, Wu BU, Vege SS, et al. Acute pancreatitis-progress and challenges: a report on an international symposium. Pancreas. 2015;44:1195–210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Moggia E, Koti R, Belgaumkar AP, Fazio F, Pereira SP, Davidson BR, et al. Pharmacological interventions for acute pancreatitis. Cochrane Database Syst Rev. 2017;4:CD011384.

    PubMed  Google Scholar 

  9. Singh VK, Moran RA, Afghani E, de-Madaria E. Treating acute pancreatitis: what’s new? Expert Rev Gastroenterol Hepatol. 2015;9:901–11.

    Article  CAS  PubMed  Google Scholar 

  10. • Mounzer R, Langmead CJ, Wu BU, Evans AC, Bishehsari F, Muddana V, et al. Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis. Gastroenterology. 2012;142:6. First study, utilizing prospectively collected data, showing that the positive predictive value of current clinical scoring systems to predict persistent organ failure (severe acute pancreatitis) is low.

    Article  Google Scholar 

  11. Johnson CD, Kingsnorth AN, Imrie CW, McMahon MJ, Neoptolemos JP, McKay C, et al. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut. 2001;48:62–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Zhao G, Zhang JG, Wu HS, Tao J, Qin Q, Deng SC, et al. Effects of different resuscitation fluid on severe acute pancreatitis. World J Gastroenterol. 2013;19:2044–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Vege SS, Atwal T, Bi Y, Chari ST, Clemens MA, Enders FT. Pentoxifylline treatment in severe acute pancreatitis: a pilot, double-blind, placebo-controlled, randomized trial. Gastroenterology. 2015;149:20.e3.

    Article  CAS  Google Scholar 

  14. • Buxbaum JL, Quezada M, Da B, Jani N, Lane C, Mwengela D, et al. Early aggressive hydration hastens clinical improvement in mild acute pancreatitis. Am J Gastroenterol. 2017;112:797–803 First RCT showing that aggressive hydration with lactated Ringer’s reduces the time to clinical improvement in patients with mild AP compared to standard hydration regimen.

    Article  PubMed  Google Scholar 

  15. Vege SS, DiMagno MJ, Forsmark CE, Martel M, Barkun AN. Initial medical treatment of acute pancreatitis: American Gastroenterological Association Institute Technical Review. Gastroenterology. 2018;154:1103–39.

  16. Haydock MD, Mittal A, van den Heever M, Rossaak JI, Connor S, Rodgers M, et al. Pancreas network of New Zealand. National survey of fluid therapy in acute pancreatitis: current practice lacks a sound evidence base. World J Surg. 2013;37:2428–35.

    Article  PubMed  Google Scholar 

  17. de-Madaria E, Martinez J, Perez-Mateo M. The dynamic nature of fluid resuscitation in acute pancreatitis. Clin Gastroenterol Hepatol. 2012;10:6 author reply 96.

  18. de-Madaria E, Banks PA, Moya-Hoyo N, Wu BU, Rey-Riveiro M, Acevedo-Piedra NG, et al. Early factors associated with fluid sequestration and outcomes of patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2014;12:997–1002.

    Article  PubMed  Google Scholar 

  19. Wu BU, Hwang JQ, Gardner TH, Repas K, Delee R, Yu S, et al. Lactated Ringer’s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011;9:717.e1.

    Article  Google Scholar 

  20. de-Madaria E, Herrera-Marante I, Gonzalez-Camacho V, Bonjoch L, Quesada-Vazquez N, Almenta-Saavedra I, et al. Fluid resuscitation with lactated Ringer's solution vs normal saline in acute pancreatitis: a triple-blind, randomized, controlled trial. United European Gastroenterol J. 2018;6:63–72.

    Article  PubMed  Google Scholar 

  21. Bhoomagoud M, Jung T, Atladottir J, Kolodecik TR, Shugrue C, Chaudhuri A, et al. Reducing extracellular pH sensitizes the acinar cell to secretagogue-induced pancreatitis responses in rats. Gastroenterology. 2009;137:1083–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Noble MD, Romac J, Vigna SR, Liddle RA. A pH-sensitive, neurogenic pathway mediates disease severity in a model of post-ERCP pancreatitis. Gut. 2008;57:1566–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513:559–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Iraporda C, Errea A, Romanin DE, Cayet D, Pereyra E, Pignataro O, et al. Lactate and short chain fatty acids produced by microbial fermentation downregulate proinflammatory responses in intestinal epithelial cells and myeloid cells. Immunobiology. 2015;220:1161–9.

    Article  CAS  PubMed  Google Scholar 

  25. Singh VK, Gardner TB, Papachristou GI, Rey-Riveiro M, Faghih M, Koutroumpakis E, et al. An international multicenter study of early intravenous fluid administration and outcome in acute pancreatitis. United European Gastroenterol J. 2017;5:491–8.

    Article  PubMed  Google Scholar 

  26. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med. 2012;367:124–34.

    Article  CAS  PubMed  Google Scholar 

  27. Wiedermann CJ, Eisendle K. Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines Agency. J Pharm Policy Pract. 2017;10:6. eCollection 2017.

  28. Opperer M, Poeran J, Rasul R, Mazumdar M, Memtsoudis SG. Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis. BMJ. 2015;350:h1567.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wiedermann CJ. Hydroxyethyl starch--can the safety problems be ignored? Wien Klin Wochenschr. 2004;116:583–94.

    Article  CAS  PubMed  Google Scholar 

  30. Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 2013;13:1.

  31. Jin T, Jiang K, Deng L, Guo J, Wu Y, Wang Z, Shi N, Zhang X, Lin Z, Asrani V, Jones P, Mittal A, Phillips A, Sutton R, Huang W, Yang X, Xia Q, Windsor JA. Response and outcome from fluid resuscitation in acute pancreatitis: a prospective cohort study. HPB (Oxford). 2018.

  32. Crockett SD, Wani S, Gardner TB, Falck-Ytter Y, Barkun AN. American Gastroenterological Association Institute Clinical Guidelines Committee. American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis. Gastroenterology. 2018;154:1096–101.

    Article  PubMed  Google Scholar 

  33. Capurso G, Zerboni G, Signoretti M, Valente R, Stigliano S, Piciucchi M, et al. Role of the gut barrier in acute pancreatitis. J Clin Gastroenterol. 2012;46(Suppl):46.

    Article  Google Scholar 

  34. • Bakker OJ, van Brunschot S, van Santvoort HC, Besselink MG, Bollen TL, Boermeester MA, et al. Early versus on-demand nasoenteric tube feeding in acute pancreatitis. N Engl J Med. 2014;371:1983–93 This is the first study to show that similar outcomes can be achieved in patients randomized to an oral diet versus enteral feeds through nasojejunal tube in patients with predicted severe acute pancreatitis.

    Article  CAS  PubMed  Google Scholar 

  35. Vaughn VM, Shuster D, Rogers MAM, Mann J, Conte ML, Saint S, et al. Early versus delayed feeding in patients with acute pancreatitis: a systematic review. Ann Intern Med. 2017;166:883–92.

    Article  PubMed  Google Scholar 

  36. Whitlock TL, Repas K, Tignor A, Conwell D, Singh V, Banks PA, et al. Early readmission in acute pancreatitis: incidence and risk factors. Am J Gastroenterol. 2010;105:2492–7.

    Article  PubMed  Google Scholar 

  37. Li W, Liu J, Zhao S, Li J. Safety and efficacy of total parenteral nutrition versus total enteral nutrition for patients with severe acute pancreatitis: a meta-analysis. J Int Med Res. 2018;46:3948–58.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Song J, Zhong Y, Lu X, Kang X, Wang Y, Guo W, et al. Enteral nutrition provided within 48 hours after admission in severe acute pancreatitis: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97:e11871.

    Article  Google Scholar 

  39. Zhu Y, Yin H, Zhang R, Ye X, Wei J. Nasogastric nutrition versus nasojejunal nutrition in patients with severe acute pancreatitis: a meta-analysis of randomized controlled trials. Gastroenterol Res Pract. 2016;2016:6430632.

    PubMed  PubMed Central  Google Scholar 

  40. Basurto Ona X, Rigau Comas D, Urrutia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev. 2013;(7):CD009179. doi:CD009179.

  41. Gulen B, Dur A, Serinken M, Karcioglu O, Sonmez E. Pain treatment in patients with acute pancreatitis: a randomized controlled trial. Turk J Gastroenterol. 2016;27:192–6.

    Article  PubMed  Google Scholar 

  42. Meng W, Yuan J, Zhang C, Bai Z, Zhou W, Yan J, et al. Parenteral analgesics for pain relief in acute pancreatitis: a systematic review. Pancreatology. 2013;13:201–6.

    Article  CAS  PubMed  Google Scholar 

  43. Barlass U, Dutta R, Cheema H, George J, Sareen A, Dixit A, et al. Morphine worsens the severity and prevents pancreatic regeneration in mouse models of acute pancreatitis. Gut. 2018;67:600–2.

    PubMed  Google Scholar 

  44. Sadowski SM, Andres A, Morel P, Schiffer E, Frossard JL, Platon A, et al. Epidural anesthesia improves pancreatic perfusion and decreases the severity of acute pancreatitis. World J Gastroenterol. 2015;21:12448–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Bulyez S, Pereira B, Caumon E, Imhoff E, Roszyk L, Bernard L, et al. AzuRea network Epidural analgesia in critically ill patients with acute pancreatitis: the multicentre randomised controlled EPIPAN study protocol. BMJ Open. 2017;7:015280.

    Article  Google Scholar 

  46. Cui ML, Kim KH, Kim HG, Han J, Kim H, Cho KB, et al. Incidence, risk factors and clinical course of pancreatic fluid collections in acute pancreatitis. Dig Dis Sci. 2014;59:1055–62.

    Article  PubMed  Google Scholar 

  47. Varadarajulu S, Bang JY, Sutton BS, Trevino JM, Christein JD, Wilcox CM. Equal efficacy of endoscopic and surgical cystogastrostomy for pancreatic pseudocyst drainage in a randomized trial. Gastroenterology. 2013;145:90.e1.

    Article  Google Scholar 

  48. Alali A, Mosko J, May G, Teshima C. Endoscopic ultrasound-guided management of pancreatic fluid collections: update and review of the literature. Clin Endosc. 2017;50:117–25.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Besselink MG, Verwer TJ, Schoenmaeckers EJ, Buskens E, Ridwan BU, Visser MR, et al. Timing of surgical intervention in necrotizing pancreatitis. Arch Surg. 2007;142:1194–201.

    Article  PubMed  Google Scholar 

  50. Connor S, Ghaneh P, Raraty M, Sutton R, Rosso E, Garvey CJ, et al. Minimally invasive retroperitoneal pancreatic necrosectomy. Dig Surg. 2003;20:270–7.

    Article  CAS  PubMed  Google Scholar 

  51. Bakker OJ, van Santvoort HC, van Brunschot S, Geskus RB, Besselink MG, Bollen TL, et al. Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis: a randomized trial. JAMA. 2012;307:1053–61.

    Article  CAS  Google Scholar 

  52. • van Brunschot S, van Grinsven J, van Santvoort HC, Bakker OJ, Besselink MG, Boermeester MA, et al. Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial. Lancet. 2018;391:51–8. This RCT compared the endoscopic and surgical step-up approaches to symptomatic walled-off necrosis and showed that surgery was not superior to endoscopy with regard to both clinical and economic outcomes.

    Article  Google Scholar 

  53. Chandrasekaran P, Gupta R, Shenvi S, Kang M, Rana SS, Singh R, et al. Prospective comparison of long term outcomes in patients with severe acute pancreatitis managed by operative and non operative measures. Pancreatology. 2015;15:478–84.

    Article  PubMed  Google Scholar 

  54. Sharaiha RZ, Tyberg A, Khashab MA, Kumta NA, Karia K, Nieto J, et al. Endoscopic therapy with lumen-apposing metal stents is safe and effective for patients with pancreatic walled-off necrosis. Clin Gastroenterol Hepatol. 2016;14:1797–803.

    Article  PubMed  Google Scholar 

  55. Siddiqui AA, Adler DG, Nieto J, Shah JN, Binmoeller KF, Kane S, et al. EUS-guided drainage of peripancreatic fluid collections and necrosis by using a novel lumen-apposing stent: a large retrospective, multicenter U.S. experience (with videos). Gastrointest Endosc. 2016;83:699–707.

    Article  PubMed  Google Scholar 

  56. Bapaye A, Itoi T, Kongkam P, Dubale N, Mukai S. New fully covered large-bore wide-flare removable metal stent for drainage of pancreatic fluid collections: results of a multicenter study. Dig Endosc. 2015;27:499–504.

    Article  PubMed  Google Scholar 

  57. Rinninella E, Kunda R, Dollhopf M, Sanchez-Yague A, Will U, Tarantino I, et al. EUS-guided drainage of pancreatic fluid collections using a novel lumen-apposing metal stent on an electrocautery-enhanced delivery system: a large retrospective study (with video). Gastrointest Endosc. 2015;82:1039–46.

    Article  PubMed  Google Scholar 

  58. Chandran S, Efthymiou M, Kaffes A, Chen JW, Kwan V, Murray M, et al. Management of pancreatic collections with a novel endoscopically placed fully covered self-expandable metal stent: a national experience (with videos). Gastrointest Endosc. 2015;81:127–35.

    Article  PubMed  Google Scholar 

  59. Dhir V, Teoh AY, Bapat M, Bhandari S, Joshi N, Maydeo A. EUS-guided pseudocyst drainage: prospective evaluation of early removal of fully covered self-expandable metal stents with pancreatic ductal stenting in selected patients. Gastrointest Endosc. 2015;82:5.

    Google Scholar 

  60. Shah RJ, Shah JN, Waxman I, Kowalski TE, Sanchez-Yague A, Nieto J, et al. Safety and efficacy of endoscopic ultrasound-guided drainage of pancreatic fluid collections with lumen-apposing covered self-expanding metal stents. Clin Gastroenterol Hepatol. 2015;13:747–52.

    Article  PubMed  Google Scholar 

  61. Walter D, Will U, Sanchez-Yague A, Brenke D, Hampe J, Wollny H, et al. A novel lumen-apposing metal stent for endoscopic ultrasound-guided drainage of pancreatic fluid collections: a prospective cohort study. Endoscopy. 2015;47:63–7.

    Article  Google Scholar 

  62. Vazquez-Sequeiros E, Baron TH, Perez-Miranda M, Sanchez-Yague A, Gornals J, Gonzalez-Huix F, et al. Evaluation of the short- and long-term effectiveness and safety of fully covered self-expandable metal stents for drainage of pancreatic fluid collections: results of a Spanish nationwide registry. Gastrointest Endosc. 2016;84:457.e2.

    Article  Google Scholar 

  63. Nabi Z, Basha J, Reddy DN. Endoscopic management of pancreatic fluid collections-revisited. World J Gastroenterol. 2017;23:2660–72.

    Article  PubMed  PubMed Central  Google Scholar 

  64. • Bang JY, Navaneethan U, Hasan MK, Sutton B, Hawes R, Varadarajulu S. Non-superiority of lumen-apposing metal stents over plastic stents for drainage of walled-off necrosis in a randomised trial. Gut. 2018. This RCT compared plastic and metal stents for the drainage of symptomatic walled-off necrosis and showed that there was no significant difference in treatment outcomes.

  65. Werge M, Novovic S, Schmidt PN, Gluud LL. Infection increases mortality in necrotizing pancreatitis: a systematic review and meta-analysis. Pancreatology. 2016;16:698–707.

    Article  PubMed  Google Scholar 

  66. Mourad MM, Evans R, Kalidindi V, Navaratnam R, Dvorkin L, Bramhall SR. Prophylactic antibiotics in acute pancreatitis: endless debate. Ann R Coll Surg Engl. 2017;99:107–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Lee HS, Lee SK, Park DH, Lee SS, Seo DW, Kim MH, et al. Emergence of multidrug resistant infection in patients with severe acute pancreatitis. Pancreatology. 2014;14:450–3.

    Article  PubMed  Google Scholar 

  68. Brown LA, Hore TA, Phillips AR, Windsor JA, Petrov MS. A systematic review of the extra-pancreatic infectious complications in acute pancreatitis. Pancreatology. 2014;14:436–43.

    Article  PubMed  Google Scholar 

  69. • Guo Q, Li A, Xia Q, Liu X, Tian B, Mai G, et al. The role of organ failure and infection in necrotizing pancreatitis: a prospective study. Ann Surg. 2014;259:1201–7. One of the first large studies to show that organ failure is a stronger determinant of mortality in patients with necrotizing pancreatitis as compared with local infection.

    Article  PubMed  Google Scholar 

  70. Besselink MG, van Santvoort HC, Boermeester MA, Nieuwenhuijs VB, van Goor H, Dejong CH, et al. Timing and impact of infections in acute pancreatitis. Br J Surg. 2009;96:267–73.

    Article  CAS  PubMed  Google Scholar 

  71. Mouli VP, Sreenivas V, Garg PK. Efficacy of conservative treatment, without necrosectomy, for infected pancreatic necrosis: a systematic review and meta-analysis. Gastroenterology. 2013;144:340.e2.

    Article  Google Scholar 

  72. • Kochar B, Akshintala VS, Afghani E, Elmunzer BJ, Kim KJ, Lennon AM, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc. 2015;81:149.e9. This systematic review of the placebo and no-stent arms of 108 RCTs provides accurate incidence estimates of PEP, severe PEP, and PEP-associated mortality which can be used for sample size calculations for future RCT as well as patient informed consent for ERCP procedures.

    Article  Google Scholar 

  73. Andrade-Davila VF, Chavez-Tostado M, Davalos-Cobian C, Garcia-Correa J, Montano-Loza A, Fuentes-Orozco C, et al. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial. BMC Gastroenterol. 2015;15:2.

    Article  CAS  Google Scholar 

  74. Luo H, Zhao L, Leung J, Zhang R, Liu Z, Wang X, et al. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial. Lancet. 2016;387:2293–301.

    Article  CAS  PubMed  Google Scholar 

  75. Thiruvengadam NR, Forde KA, Ma GK, Ahmad N, Chandrasekhara V, Ginsberg GG, et al. Rectal indomethacin reduces pancreatitis in high- and low-risk patients undergoing endoscopic retrograde cholangiopancreatography. Gastroenterology. 2016;151:297.e4.

    Article  CAS  Google Scholar 

  76. Del Olmo ML, Velayos Jimenez B, Almaraz GA. Rectal diclofenac does not prevent post-ERCP pancreatitis in consecutive high-risk and low-risk patients. Rev Esp Enferm Dig. 2018;110. https://doi.org/10.17235/reed.2018.5259/2017.

  77. Okuno M, Shiroko J, Taguchi D, Yamaguchi K, Takada J, Imai S, Sato H, Thanabashi S. The effectiveness of the rectal administration of low-dose diclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Intern Med. 2018.

  78. de Quadros OF, Lima JCP, Watte G, Lehmen RL, Oba D, Camargo G, et al. C E O Prophylaxis of pancreatitis with intravenous ketoprofen in a consecutive population of ERCP patients: a randomized double-blind placebo-controlled trial. Surg Endosc. 2017;31:2317–24.

    Article  Google Scholar 

  79. • Elmunzer BJ, Scheiman JM, Lehman GA, Chak A, Mosler P, Higgins PD, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366:1414–22. First adequately powered RCT to show the efficacy of rectal indomethacin for the prevention of post-ERCP pancreatitis in high-risk patients compared to placebo.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Kato K, Shiba M, Kakiya Y, Maruyama H, Ominami M, Fukunaga S, et al. Celecoxib oral administration for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized prospective trial. Pancreas. 2017;46:880–6.

    Article  CAS  PubMed  Google Scholar 

  81. Park SW, Chung MJ, Oh TG, Park JY, Bang S, Park SW, et al. Intramuscular diclofenac for the prevention of post-ERCP pancreatitis: a randomized trial. Endoscopy. 2015;47:33–9.

    PubMed  Google Scholar 

  82. Choksi NS, Fogel EL, Cote GA, Romagnuolo J, Elta GH, Scheiman JM, et al. The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement. Gastrointest Endosc. 2015;81:150–5.

    Article  PubMed  Google Scholar 

  83. •• Elmunzer BJ, Serrano J, Chak A, Edmundowicz SA, Papachristou GI, Scheiman JM, et al. Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial. Trials. 2016;17:2. Ongoing RCT, currently in its 4th year (planned 5-year trial), testing the hypothesis that rectal indomethacin is noninferior to the combination of rectal indomethacin and pancreatic stent placement for the prevention of post-ERCP pancreatitis in high-risk patients.

    Article  CAS  Google Scholar 

  84. • Choi JH, Kim HJ, Lee BU, Kim TH, Song IH. Vigorous Periprocedural hydration with lactated Ringer’s solution reduces the risk of pancreatitis after retrograde cholangiopancreatography in hospitalized patients. Clin Gastroenterol Hepatol. 2017;15:92.e1. First RCT to show that periprocedural fluid therapy with lactated Ringer’s reduces the incidence and severity of post-ERCP pancreatitis in average-risk patients.

    Google Scholar 

  85. Mok SRS, Ho HC, Shah P, Patel M, Gaughan JP, Elfant AB. Lactated Ringer’s solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial. Gastrointest Endosc. 2017;85:1005–13.

    Article  PubMed  Google Scholar 

  86. Smeets XJNM, da Costa DW, Fockens P, Mulder CJJ, Timmer R, Kievit W, et al. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial. Trials. 2018;19:x.

    Article  CAS  Google Scholar 

  87. de Pretis N, Amodio A, Frulloni L. Hypertriglyceridemic pancreatitis: epidemiology, pathophysiology and clinical management. United European Gastroenterol J. 2018;6:649–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Scherer J, Singh VP, Pitchumoni CS, Yadav D. Issues in hypertriglyceridemic pancreatitis: an update. J Clin Gastroenterol. 2014;48:195–203.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. • Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Intern Med. 2016;176:1834–42. Large population-based study from Scandanavia that showed an increased risk of AP in patients with lower triglyceride levels than prior studies.

    Article  PubMed  Google Scholar 

  90. Christian JB, Bourgeois N, Snipes R, Lowe KA. Prevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adults. Am J Cardiol. 2011;107:891–7.

    Article  CAS  PubMed  Google Scholar 

  91. Nawaz H, Koutroumpakis E, Easler J, Slivka A, Whitcomb DC, Singh VP, et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am J Gastroenterol. 2015;110:1497–503.

    Article  CAS  PubMed  Google Scholar 

  92. Christian JB, Arondekar B, Buysman EK, Jacobson TA, Snipes RG, Horwitz RI. Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia. Am J Med. 2014;127:44.e1.

    Article  CAS  Google Scholar 

  93. Ahmad Z, Halter R, Stevenson M. Building a better understanding of the burden of disease in familial chylomicronemia syndrome. Expert Rev Clin Pharmacol. 2017;10:1–3.

    Article  CAS  PubMed  Google Scholar 

  94. Brahm AJ, Hegele RA. Chylomicronaemia--current diagnosis and future therapies. Nat Rev Endocrinol. 2015;11:352–62.

    Article  CAS  PubMed  Google Scholar 

  95. Stroes E, Moulin P, Parhofer KG, Rebours V, Lohr JM, Averna M. Diagnostic algorithm for familial chylomicronemia syndrome. Atheroscler Suppl. 2017;23:1–7.

    Article  PubMed  Google Scholar 

  96. Hwang SS, Li BH, Haigh PI. Gallstone pancreatitis without cholecystectomy. JAMA Surg. 2013;148:867–72.

    Article  PubMed  Google Scholar 

  97. Yadav D, O'Connell M, Papachristou GI. Natural history following the first attack of acute pancreatitis. Am J Gastroenterol. 2012;107:1096–103.

    Article  PubMed  Google Scholar 

  98. da Costa DW, Dijksman LM, Bouwense SA, Schepers NJ, Besselink MG, van Santvoort HC, et al. Dutch Pancreatitis Study Group. Cost-effectiveness of same-admission versus interval cholecystectomy after mild gallstone pancreatitis in the PONCHO trial. Br J Surg. 2016;103:1695–703.

    Article  PubMed  Google Scholar 

  99. • Schepers NJ, on behalf of the Dutch Pancreatitis Study Group. Early endoscopic retrograde cholangiography with biliary sphincterotomy or conservative treatment in predicted severe acute biliary pancreatitis (Apec): a multicenter randomized controlled trial, In: UEG week 2018; October 20-24; Austria. United European Gastroenterol J. 2018;6(8S):A1–A134 The preliminary data from this RCT shows that, in patients with predicted severe acute biliary pancreatitis without cholangitis, early ERC within 24 h of presentation to the emergency department did not reduce mortality.

    Google Scholar 

  100. Ahmed Ali U, Issa Y, Hagenaars JC, Bakker OJ, van Goor H, Nieuwenhuijs VB, et al. Dutch Pancreatitis Study Group. Risk of recurrent pancreatitis and progression to chronic pancreatitis after a first episode of acute pancreatitis. Clin Gastroenterol Hepatol. 2016;14:738–46.

    Article  PubMed  Google Scholar 

  101. Nordback I, Pelli H, Lappalainen-Lehto R, Jarvinen S, Raty S, Sand J. The recurrence of acute alcohol-associated pancreatitis can be reduced: a randomized controlled trial. Gastroenterology. 2009;136:848–55.

    Article  PubMed  Google Scholar 

  102. Han S, Kheder J, Bocelli L, Fahed J, Wachholtz A, Seward G, et al. Smoking cessation in a chronic pancreatitis population. Pancreas. 2016;45:1303–8.

    Article  PubMed  PubMed Central  Google Scholar 

  103. https://www.proteinatlas.org/ENSG00000001626-CFTR/tissue#gene_information.

  104. • Ooi CY, Dorfman R, Cipolli M, Gonska T, Castellani C, Keenan K, et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology. 2011;140:153–61 This is the first study showing the risk of pancreatitis across different CFTR genotypes in patients with cystic fibrosis.

    Article  CAS  PubMed  Google Scholar 

  105. LaRusch J, Jung J, General IJ, Lewis MD, Park HW, Brand RE, et al. Mechanisms of CFTR functional variants that impair regulated bicarbonate permeation and increase risk for pancreatitis but not for cystic fibrosis. PLoS Genet. 2014;10:e1004376.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Carrion A, Borowitz DS, Freedman SD, Siracusa CM, Goralski JL, Hadjiliadis D, et al. Reduction of recurrence risk of pancreatitis in cystic fibrosis with ivacaftor: case series. J Pediatr Gastroenterol Nutr. 2018;66:451–4.

    Article  PubMed  Google Scholar 

  107. Lagoo JY, D'Souza MC, Kartha A, Kutappa AM. Role of ulinastatin, a trypsin inhibitor, in severe acute pancreatitis in critical care setting: a retrospective analysis. J Crit Care. 2018;45:27–32.

    Article  CAS  PubMed  Google Scholar 

  108. Wang LZ, Luo MY, Zhang JS, Ge FG, Chen JL, Zheng CQ. Effect of ulinastatin on serum inflammatory factors in Asian patients with acute pancreatitis before and after treatment: a meta-analysis. Int J Clin Pharmacol Ther. 2016;54:890–8.

    Article  PubMed  Google Scholar 

  109. Xu B, Bai B, Sha S, Yu P, An Y, Wang S, et al. Interleukin-1beta induces autophagy by affecting calcium homeostasis and trypsinogen activation in pancreatic acinar cells. Int J Clin Exp Pathol. 2014;7:3620–31.

    CAS  PubMed  PubMed Central  Google Scholar 

  110. Chao KC, Chao KF, Chuang CC, Liu SH. Blockade of interleukin 6 accelerates acinar cell apoptosis and attenuates experimental acute pancreatitis in vivo. Br J Surg. 2006;93:332–8.

    Article  CAS  PubMed  Google Scholar 

  111. Mazzon E, Impellizzeri D, Di Paola R, Paterniti I, Esposito E, Cappellani A, et al. Effects of mitogen-activated protein kinase signaling pathway inhibition on the development of cerulein-induced acute pancreatitis in mice. Pancreas. 2012;41:560–70.

    Article  CAS  PubMed  Google Scholar 

  112. Xu P, Wang J, Yang ZW, Lou XL, Chen C. Regulatory roles of the PI3K/Akt signaling pathway in rats with severe acute pancreatitis. PLoS One. 2013;8:e81767.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Johns Hopkins Medical Institutions, 1830 E. Monument Street, Room 428, Baltimore, MD, 21205, USA

    Mahya Faghih MD & Vikesh K. Singh MD, MSc

  2. Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA

    Christopher Fan MD

  3. Pancreatitis Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA

    Vikesh K. Singh MD, MSc

Authors
  1. Mahya Faghih MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher Fan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vikesh K. Singh MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vikesh K. Singh MD, MSc.

Ethics declarations

Conflict of interest

Mahya Faghih declares that she has no conflict of interest. Christopher Fan declares that he has no conflict of interest. Vikesh Singh reports personal fees from AbbVie, Akcea Therapeutics, Ariel Precision Medicine, and Orgenesis.

Human and animal rights and informed consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Pancreas

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faghih, M., Fan, C. & Singh, V.K. New Advances in the Treatment of Acute Pancreatitis. Curr Treat Options Gastro 17, 146–160 (2019). https://doi.org/10.1007/s11938-019-00223-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11938-019-00223-8

Keywords

Search

Navigation